This ETF is trying to satisfy appetites for weight loss stocks
Tema ETFs has been capitalizing on the risk appetite for weight loss stocks. It is behind the GLP-1, Obesity &…
‘Early innings’ of a U.S. manufacturing boom: Tema ETFs CEO delivers bull case for industrials
One exchange-traded fund is betting on a U.S. manufacturing job resurgence. Tema ETFs CEO and founder Maurits Pot is behind…
Is the U.S. stock market too ‘concentrated’? Here’s what to know
The U.S. stock market has become dominated by about a handful of companies in recent years. Some experts question whether…
Growth, value stocks could see boost from Russell rebalancing
A bullish move may be ahead for both value and growth in the year’s second half. VettaFi’s Todd Rosenbluth thinks…
This ETF strategy may help investors skirt market concentration risk
Investors worried about concentration risk in the market may want to consider value-oriented investments. Avantis Investors chief investment strategist Phil…
Retail investors may be a step closer to investing in unicorns
An alternative trading platform CEO wants to revolutionize private equity investing to help mitigate a stalling initial public offering market.…
The SEC ruling on Ethereum ETFs could mark a historic shift in crypto investing
VanEck CEO Jan van Eck sees a major sentiment shift underway in the cryptocurrency market linked to the U.S. Securities…
This new weight loss drug ETF bets big on two of the industry’s leading players
A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs. Roundhill Investments’ GLP-1 &…
This ETF aims to capture China’s own ‘Magnificent Seven’
Roundhill Investments wants to mimic the success of its Magnificent Seven ETF (MAGS) in China. The firm’s CEO Dave Mazza…
No ‘cop on the beat’: Why the SEC may deny new ether ETFs this month
The U.S. Securities and Exchange Commission is expected to make a key decision on approving ether exchange-traded funds next week.…
